Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414255 · ClinicalTrials.gov registry record · Phase 3
Micronized dHACM Injectable for the Treatment of Achille Tendonitis
A Phase 3 study, sponsored by MiMedx Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 146
- Enrollment target
NCT03414255: Completed Phase 3 study, sponsored by MiMedx Group.
NCT03414255 is a Phase 3 study that has completed, run by MiMedx Group. The registered enrollment target is 146 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03414255, a Phase 3 study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 146 participants
- Enrollment target
Study Summary
Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis
Primary Outcome
Visual Analog Scale, Left end point is "No Pain". Right end point is "worst pain imaginable"
Interventions
- DRUG Saline Injection
- BIOLOGICAL Micronized DHACM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2021-03-30 |
| Phase | Phase 3 |
What the finished NCT03414255 record still lists
NCT03414255 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline Injection is the first listed.
NCT03414255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03414255 about?
NCT03414255 is a clinical study titled "Micronized dHACM Injectable for the Treatment of Achille Tendonitis". Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis
What is the current status of trial NCT03414255?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 146 participants. The study started on 2018-01-09. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03414255?
The interventions under investigation include: Saline Injection (DRUG), Micronized DHACM (BIOLOGICAL).
Who is sponsoring clinical trial NCT03414255?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03414255's enrollment target sits among peer trials
146 1551st of 2000 higher than 446 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI